Healthcare provider profile · identity verified

Michael Eugene Steele, MD

Family Practice · CLARKSVILLE, TN · NPI 1427187673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	344	169
Lisinopril	Lisinopril	280	127
Amlodipine Besylate	Amlodipine Besylate	259	129
Levothyroxine Sodium	Levothyroxine Sodium	236	107
Gabapentin	Gabapentin	208	82
Losartan Potassium	Losartan Potassium	191	99
Omeprazole	Omeprazole	185	97
Metformin Hcl	Metformin Hcl	132	66
Trazodone Hcl	Trazodone Hcl	130	64
Simvastatin	Simvastatin	114	56
Hydrochlorothiazide	Hydrochlorothiazide	110	53
Metoprolol Succinate	Metoprolol Succinate	107	61
Pantoprazole Sodium	Pantoprazole Sodium	106	51
Albuterol Sulfate Hfa	Albuterol Sulfate	103	48
Rosuvastatin Calcium	Rosuvastatin Calcium	96	51
Tamsulosin Hcl	Tamsulosin Hcl	92	40
Fluticasone Propionate	Fluticasone Propionate	81	39
Metformin Hcl Er	Metformin Hcl	79	40
Duloxetine Hcl	Duloxetine Hcl	77	36
Carvedilol	Carvedilol	76	39
Metoprolol Tartrate	Metoprolol Tartrate	71	31
Sertraline Hcl	Sertraline Hcl	70	33
Meloxicam	Meloxicam	69	35
Pravastatin Sodium	Pravastatin Sodium	67	33
Prednisone	Prednisone	66	58
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	22
Citalopram Hbr	Citalopram Hydrobromide	62	28
Furosemide	Furosemide	58	30
Escitalopram Oxalate	Escitalopram Oxalate	56	30
Eliquis	Apixaban	55	16
Montelukast Sodium	Montelukast Sodium	55	35
Tramadol Hcl	Tramadol Hcl	54	17
Potassium Chloride	Potassium Chloride	53	23
Ozempic	Semaglutide	52	17
Tizanidine Hcl	Tizanidine Hcl	52	22
Januvia	Sitagliptin Phosphate	51	21
Clopidogrel	Clopidogrel Bisulfate	50	24
Allopurinol	Allopurinol	49	25
Famotidine	Famotidine	47	23
Mounjaro	Tirzepatide	47	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	18
Glimepiride	Glimepiride	43	21
Mirtazapine	Mirtazapine	41	17
Lovastatin	Lovastatin	40	21
Alprazolam	Alprazolam	39	14
Celecoxib	Celecoxib	39	17
Chlorthalidone	Chlorthalidone	34	17
Farxiga	Dapagliflozin Propanediol	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	21
Atenolol	Atenolol	32	14
Aripiprazole	Aripiprazole	31	13
Nifedipine Er	Nifedipine	30	14
Quetiapine Fumarate	Quetiapine Fumarate	30	11
Benazepril Hcl	Benazepril Hcl	29	15
Hydralazine Hcl	Hydralazine Hcl	29	12
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Azithromycin	Azithromycin	28	25
Esomeprazole Magnesium	Esomeprazole Magnesium	27	12
Finasteride	Finasteride	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	14
Glipizide	Glipizide	26	14
Ropinirole Hcl	Ropinirole Hcl	26	11
Bupropion Xl	Bupropion Hcl	25	15
Dicyclomine Hcl	Dicyclomine Hcl	25	11
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	11
Jardiance	Empagliflozin	23	13
Clonazepam	Clonazepam	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Clonidine Hcl	Clonidine Hcl	21	11
Pregabalin	Pregabalin	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	11
Doxycycline Hyclate	Doxycycline Hyclate	20	13
Lamotrigine	Lamotrigine	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	11
Telmisartan	Telmisartan	20	14
Venlafaxine Hcl Er	Venlafaxine Hcl	20	11
Ezetimibe	Ezetimibe	19	12
Fenofibrate	Fenofibrate	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	11
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Buspirone Hcl	Buspirone Hcl	17	suppressed
Fluconazole	Fluconazole	17	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	11
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Levofloxacin	Levofloxacin	12	12
Moxifloxacin Hcl	Moxifloxacin Hcl	12	11
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	11
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Estradiol	Estradiol	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error